BRIEF published on 10/28/2025 at 17:55, 1 year ago FUTRUE ajuste la rémunération en espèces pour le retrait forcé de PharmaSGP Assemblée Générale Squeeze-out Compensation En Espèces PharmaSGP Futrue GmbH
BRIEF published on 10/28/2025 at 17:55, 1 year ago FUTRUE Adjusts Cash Compensation for PharmaSGP Squeeze-Out General Meeting Squeeze-out Cash Compensation PharmaSGP Futrue GmbH
PRESS RELEASE published on 10/28/2025 at 17:50, 1 year ago FUTRUE increases adequate cash compensation under the squeeze-out FUTRUE increases adequate cash compensation under squeeze-out for PharmaSGP Holding SE minority shareholders. Cash compensation raised to EUR 30.64 per share effective immediately Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE FUTRUE
BRIEF published on 09/22/2025 at 15:20, 1 year 1 month ago PharmaSGP Calls Extraordinary General Meeting for Squeeze-out Decision General Meeting Squeeze-out Share Transfer PharmaSGP Futrue GmbH
BRIEF published on 09/22/2025 at 15:20, 1 year 1 month ago PharmaSGP convoque une assemblée générale extraordinaire pour prendre une décision de retrait obligatoire Assemblée Générale Transfert D'actions PharmaSGP Retrait Forcé Futrue GmbH
PRESS RELEASE published on 09/22/2025 at 15:15, 1 year 1 month ago PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out PharmaSGP Holding SE convenes an extraordinary general meeting to resolve on squeeze-out of remaining shareholders. Cash compensation specified at EUR 29.33 per share Extraordinary General Meeting Squeeze-out Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 09/11/2025 at 09:05, 1 year 1 month ago PharmaSGP Releases Preliminary Half-Year Figures for 2025 Adjusted EBITDA Germany PharmaSGP OTC Pharmaceuticals 2025 Revenues
BRIEF published on 09/11/2025 at 09:05, 1 year 1 month ago PharmaSGP publie ses chiffres préliminaires du premier semestre 2025 Allemagne EBITDA Ajusté PharmaSGP Chiffre D'affaires 2025 Médicaments En Vente Libre
PRESS RELEASE published on 09/11/2025 at 09:00, 1 year 1 month ago PharmaSGP publishes preliminary half-year figures for 2025 PharmaSGP Holding SE releases preliminary half-year figures for 2025, showing a 13.0% revenue increase. Adjusted EBITDA declined slightly due to higher expenses. Forecast aims for continued growth amidst global uncertainties Adjusted EBITDA Revenue Increase Growth Forecast PharmaSGP Half-Year Figures
BRIEF published on 08/06/2025 at 16:21, 1 year 2 months ago PharmaSGP annonce sa radiation de la Bourse de Francfort Bourse Bourse De Francfort Radiation PharmaSGP Futrue GmbH
Published on 10/30/2026 at 23:35, 18 hours 12 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 18 hours 17 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 22 hours 47 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 2 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 1 hour 12 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 18 hours 58 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 18 hours 47 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 18 hours 47 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
